Continuous Glucose Monitoring System in Intensive Care Unit

Completed

• Conditions: Diabetic Blood Glucose Monitoring

• Registration Number: NCT01995994
• Lead Sponsor: Seoul National University Hospital

Brief Summary

To assess the accuracy, safety, and influence of sampling site of Real-time continuous glucose monitoring system (Medtronic Guardian).

Detailed Description

Not available

Study Timeline

• Study Start: 2012-06
• Status Verified: 2013-11
• Primary Completion: 2013-11
• Study First Submitted: 2013-11-21
• Study First Submitted QC: 2013-11-26
• Study First Posted: 2013-11-27
• Study Completion: 2014-02
• Last Update Submitted: 2015-05-19
• Last Update Posted: 2015-05-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

• Older than 18 years old
• Staying in intensive care units longer than 72 hours

Read More

Exclusion Criteria

• Skin disease
• DIC
• Immune suppressed patients

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference between finger stick blood glucose and real-time continuous glucose monitoring	72 hours

Secondary Outcome Measures

Name	Time	Method
Measurement error of real-time continuous glucose monitoring	72 hours

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of